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ABSTRACT 
Background: Oral candidiasis is an infection caused by commensal 
fungi of Candida species in the oral cavity that serves as an 
opportunistic pathogen with Candida albicans (C. albicans) as the 
most frequent (80%) etiology. The prevalence of oral candidiasis tends 
to increase due to the increasing population of immunocompromised 
patients and resistance to anti fungal. This requires alternative 
treatment to enhance the effectivity of anti fungal medications such as 
green tea (Camellia sinensis) with (-)-epigallocatechin-3-gallate 
(EGCG) as the main polyphenol component and most potent (59-65%). 
The effect of EGCG green tea in obliterating oral candidiasis through 
neutrophil count and infected cells by C. albicans is not clearly 
determined yet up to now. Objective: To analyze the effect of EGCG  
green tea in a murine model of oral candidiasis through neutrophil  
count and infected cells by C. albicans. Method: True laboratory experimental study with 
randomized post test only control group design, using Wistar male rats. The rats were 
grouped into 1 control and 3 intervention groups. EGCG was given with the dosage of 0, 1, 2 
and 4 mg/kgBW/day as the intervention. Result: immunohistochemistry and Hematoxyllin-
eosin stain showed that EGCG green tea increased neutrophil count and decreased infected 
cells by C. albicans. Conclusion: EGCG green tea has been significantly increased neutrophil 
count and decreased infected cells by C. albicans in a murine model of oral candidiasis. 
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INTRODUCTION 
Oral candidiasis is an infection caused by commensal fungi of Candida spp. in the oral cavity 
that serves as an opportunistic pathogen.
[1-3] 
The most frequent (80%) etiology of oral 
candidiasis is Candida albicans (C. albicans).
[3-6] 
C. albicans becomes virulent in the oral 
cavity and is related to the defect on the immune system, namely immunocompromised 
conditions.
[7-8] 
The prevalence of oral candidiasis tends to increase due to the increasing 
population of immunocompromised patients as high as 50-95% (Diabetes Mellitus, 
immunosuppresant drugs or long term antibiotics usage, Human Immunodeficiency Virus 
(HIV)/Acquired Immunodeficiency Syndrome (AIDS), transplant organ recipients, and 
hyposalivation).
[6, 9-12] 
Aside from those, the increased prevalence of oral candidiasis is also 
induced by the high number of resistant cases to anti fungal medications (32->50%).
[6, 13-16]
 
All of those lead to the increasing failure of anti fungal medications (azole), which can lead 
to systemic candidiasis occurs with mortality of 30-50%.
[5-6, 17-19]
 Therefore alternative 
treatments are needed to enhance the effectivity of anti fungal drugs. One of the alternative 
therapy is herbal drugs, including green tea (Camellia sinensis) which is already declared as 
safe for consumption or generally recognized as safe by the Food and Drug Administration 
Safety (FDA) of United States of America.
[20]
  
 
Neutrophils or polymorphonuclear lymphocytes (PMNLs) are essential innate immune cells 
which determine the host's resistance against various bacterial and fungal infections.
[21-22] 
Neutrophils have emerged as an important component of effector and regulatory circuits in 
the innate and adaptive immune systems.
[23]
 Th17 cells as component of adaptive immune 
systems, play a role in host defense to various extracellular pathogens, including fungi, 
bacteria, and some parasites. Th17 cells’ main role in antifungal immunity is at sites of 
infection in the skin and mucosa through the release of proinflammatory factors, recruitment 
of neutrophils, and production of antimicrobial peptides.
[24]
  
 
Green tea has been known to have many benefits for human life, including being an 
immunomodulator and antifungal. The main polyphenol component (59-65%) and the most 
potent of green tea is (-)-Epigallocatechin-3-gallate (EGCG). The antifungal effects of EGCG 
were mainly studied against yeasts such as Candida spp. and moulds such as 
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dermatophytes.
[16, 25-28] 
The effect of EGCG green tea in obliterating oral candidiasis on 
neutrophil count and infected cells by C. albicans is not clearly determined yet up to now. 
Considering the essential role of neutrophil in oral candidiasis, this study was aimed to 
analyze the effect of EGCG green tea in obliterating oral candidiasis on neutrophil count and 
infected cells by C. albicans. 
  
MATERIALS AND METHODS 
This study was true laboratory experimental study with randomized post test only control 
group design. Male Wistar rats (n=23) (age 12 weeks; approximately 150-200 g; Animal 
Model Unit, Biochemistry Laboratory, Faculty of Medicine, Airlangga University) were used 
in this study. After acclimation for 7 days, rats were randomized into 4 groups of five or six 
animals, housed in large cages. During the experiment, food composition was complete and 
equilibrated, free from antifungal agents. The research complied with ethical clearance from 
Faculty of Dentistry – Airlangga University, No: 139/KKEPK.FKG/IX/2014, on 18 
September 2014.  
 
This study used EGCG was purchased from Xi’an Rongsheng Biotechnology Co., Ltd. (No. 
82, Keji Road, Xi’an Hitech Industries Development Zone, Shaanxi Province, P. R. China). 
Candida albicans was obtained from the Oral Biology Laboratory, Faculty of Dentistry, 
Airlangga University. A single colony from Sabouraud glucose agar was grown in yeast 
extract-peptone glucose medium YPG (yeast extract, 2%; bactopeptone, 1%; glucose, 2%) for 
18 hours at 30°C in a shaker. The culture was harvested by centrifugation at 2500g, then cells 
were washed three times in phosphate buffer saline (PBS) and adjusted to a final 
concentration of 3x10
8
 CFU/mL. The viability of the inoculum was confirmed by quantitative 
cultures of serial 10 fold dilutions on Sabouraud dextrose agar plates. To enhance the 
infection rate, rats were immunosuppressed with dexamethasone (Dexamethasone, Tianjin 
Tianyao Pharmaceuticals Co., Ltd) and treated with tetracycline hydrochloride (Tetrasanbe; 
Sanbe Farma Laboratories, Bandung, Indonesia). One week before infection, rats received 3.2 
mg/kgBW/day of dexamethasone with 120 mg/kgBW/day of tetracycline, were 
intraperitoneally (i.p.) administered to rats (day 1 until 7). On the day of infection, 
dexamethasone was raised to 6.4 mg/kgBW/day, tetracycline was reduced to 12 
mg/kgBW/day, and maintained throughout the experiment (day 8 until 22). We used 
modification model of oral candidiasis in immunosuppressed rats that was reported by 
Martinez et al.
[7]
 and Chami et al.
[29]
, with modification dosage of dexamethasone and 
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tetracycline from Thong & Ferrante
[30]
 and Brummer et al.
[31]
 The rats were orally infected 
three times at 48 h intervals (days 8, 10 and 12) with 0.1 mL of saline suspension containing 
3x10
8
 viable cells of C. albicans. Oral infection was achieved by means of a cotton swab 
rolled twice over all parts of the mouth. Just before inoculation, the animals were sampled to 
confirm the absence of C. albicans in the oral cavity, and 72 h (day 15) after the last 
inoculation all groups were sampled in the same manner to check for the presence of the 
fungi in the oral cavity before the beginning of the treatment.
[7, 29, 32] 
Just before treatment, the 
animals were sampled to confirm the presence of C. albicans in the oral cavity. Then, the 
animals were randomized and assigned to groups of four. Treatment was administered for 
seven consecutive days (from day 15 to day 22). The EGCG at 1, 2, and 4 mg/kgBW/day, 
respectively, were intraperitoneally administered to rats. The control group (n=5) received 
sterile saline by the i.p. route. Control and intervention groups were sacrificed at day 23 with 
combination of Ketamine HCl (Ketamil Injection) and Xylazine (Xyla) with 100 mg/kgBW 
and 10 mg/kgBW per intramuscular because at that time, was also conducted blood sampling 
from intracardial (3 mL) and gingival tissue excision. Samples were collected at day 15 by 
rolling a sterile cotton swab over the oral cavity, which was then suspended in 1 mL of sterile 
saline. 25μl samples from this suspension were dropped in duplicate, after serial ten fold 
dilution on Sabouraud agar plates containing 0.05% chloramphenicol. All plates were 
incubated at 30°C for 24 h.
[7, 29]
 At day 23, i.e. 24 h after the administration of the last dosage 
of EGCG or saline, the animals were sacrificed. The gingival tissues were removed, fixed in 
normal buffer formalin 10% solution for at least 48h. Gingival sections were embedded in 
paraffin and 5μm thick serial transverse sections were stained with hematoxylin-eosin stain to 
assess the neutrophil count. The infected cells by C. albicans stained with 
immunohistochemistry (Novolink™ Polymer Detection Systems). The data was processed 
with Pearson correlation using the Statistical Analysis System (SAS). 
 
RESULTS 
    
Figure 1. Identification of Candida Before Inoculation C. albicans (Day 8) 
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Prior to initiating the study, oral cavity cultures of each rat were performed, and no C. 
albicans organisms were found (Figure 1). 
 
         
Figure 2.  Hematoxyllin-eosin stain showed neutrophil count in gingival tissue 
(arrows) in each EGCG dosage group at day 23 (400 times magnification). Figure A is 
control group. EGCG dosage of 1, 2 and 4 mg/kgBW/day (Fig. B-D). 
 
The neutrophil count in gingival tissue after being evaluated with Hematoxyllin-eosin stain 
showed an increased neutrophil count compared to other treatment groups (Figure 2). 
 
        
Figure 3. Immunohistochemistry method showed infected cells by C. albicans in gingival 
tissue (arrows) in each EGCG dosage group at day 23 (400 times magnification).   
Figure A is control group. EGCG dosage of 1, 2 and 4 mg/kgBW/day (Fig. B-D). 
The infected cells by C. albicans in gingival tissue after being evaluated with 
Immunohistochemistry method showed a decreased infected cells by C. albicans compared to 
other treatment groups (Figure 3). 
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Figure 4. The results showed significant increased neutrophil count and decreased 
infected cells by C. albicans 
 
Table 1. The Pearson correlation between neutrophil count and number of C. albicans 
Correlations 
  NETROFIL CANDIDAIHC 
NETROFIL Pearson 
Correlation 
1 -.769
**
 
Sig. (2-tailed)  .000 
N 23 23 
CANDIDAIHC Pearson 
Correlation 
-.769
**
 1 
Sig. (2-tailed) .000  
N 23 23 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Figure 4 and table 1 showed significant correlation between neutrophil count and infected 
cells by C. albicans. 
 
DISCUSSION 
Neutrophils or polymorphonuclear lymphocytes (PMNLs) are essential innate immune cells 
which determine the host's resistance against various bacterial and fungal infections.
[21-22] 
Neutrophils have emerged as an important component of effector and regulatory circuits in 
the innate and adaptive immune systems. Neutrophils engage in bidirectional interactions 
with different components of both the innate and adaptive immune systems and can differen-
tially influence the response depending on the context.
[23]
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Th17 cells’ main role in antifungal immunity is at sites of infection in the skin and mucosa 
through the release of proinflammatory factors, recruitment of neutrophils, and production of 
antimicrobial peptides. Neutrophils have 3 main mechanisms to directly kill invading 
microbes: phagocytosis, degranulation and activation of the oxidative burst, and neutrophil 
extracellular traps. Microbes are taken up by phagocytosis and are then destroyed by reactive 
oxygen species with antimicrobial potential, which are produced in a process called oxidative 
or respiratory burst. Through degranulation, neutrophils release proteins with lytic and 
antimicrobial function, such as cathepsins, defensins, myeloperoxidase, and 
bactericidal/permeability-increasing protein. Finally, neutrophils can release so-called 
neutrophil extracellular traps, which act as a mesh to trap and kill microorganisms 
independently of phagocytic uptake. The traps consist of a web of DNA and histones and 
contain granule-derived proteins with antimicrobial activity.
[24]
  
 
EGCG green tea administration in this study has been significantly proven to increase 
neutrophil count in gingival tissue in each EGCG dosage group. The increasing EGCG green 
tea dosage leads to the increasing neutrophil count (Figure 4, Table 1). This might happened 
because Th17 cells’ as adaptive immune system main role in antifungal immunity is at sites 
of infection in the skin and mucosa through the release of proinflammatory factors, 
recruitment of neutrophils, and production of antimicrobial peptides.
[24]
 The effect of EGCG 
green tea through neutrophil count is not clearly determined yet up to now, but in this study 
showed increased neutrophil count.  
 
Tea is the most consumed drink in the world after water. Green tea is a ‘non-fermented’ tea 
and contains more catechins than black tea or oolong tea. Catechins are in vitro and in vivo 
strong antioxidants. In addition, its content of certain minerals and vitamins increases the 
antioxidant potential of this type of tea.
[33]
 Green tea has been known to have many benefits 
for human life, including being an immunomodulator and antifungal. The main polyphenol 
component (59-65%) and the most potent of green tea is EGCG. The antifungal effects of 
EGCG were mainly studied against yeasts such as Candida spp. and moulds such as 
dermatophytes.
[16, 25-28] 
 
EGCG green tea administration in this study has been significantly proven to decrease 
infected cells by C. albicans in each EGCG dosage group, thus it can obliterate oral 
candidiasis (Figure 4, Table 1). It was consistent with several studies that showed beside as 
main active catechin, EGCG has been known as the main polyphenol component (59-65%) 
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and the most potent of green tea, has effect as an immunomodulator and antifungal.
[16, 25-28] 
Thus, another several studies showed that EGCG green tea as antifungal was observed 
through various variable such as Minimum Inhibitory Concentration
[13, 28, 34-35]
; inhibition 
effect on C. albicans dihydrofolate reductase (DHFR), a key enzyme in the biosynthesis of 
purines, pyrimidines and several amino acids, was pH-independent
[36-37]
; EGCG also the most 
potent at retarding the formation and maintenance of Candida biofilm and to disrupt a 
preformed biofilm.
[28, 38] 
Correlation with neutrophil count and infected cells by C. albicans 
after EGCG green tea administration (Table 1) showed that the increased neutrophil count 
and the decreased infected cells by C. albicans in a murine model. 
 
CONCLUSION 
This study proved that EGCG green tea has been significantly increased neutrophil count and 
decreased infected cells by C. albicans in a murine model of oral candidiasis. 
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